Growth Metrics

Kraig Biocraft Laboratories (KBLB) Depreciation & Amortization (CF) (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $6666.0 as the latest value for Q4 2022.

  • Quarterly Depreciation & Amortization (CF) fell 2.44% to $6666.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $28102.0 through Dec 2022, up 7.52% year-over-year, with the annual reading at $25113.0 for FY2025, 4.0% down from the prior year.
  • Depreciation & Amortization (CF) hit $6666.0 in Q4 2022 for Kraig Biocraft Laboratories, down from $6716.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $9044.0 in Q3 2019 to a low of $5858.0 in Q3 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $6887.9 across 4 years, with a median of $6738.0 in 2019.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 53.01% in 2018 and later fell 2.44% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $6823.0 in 2018, then surged by 32.55% to $9044.0 in 2019, then fell by 24.45% to $6833.0 in 2021, then decreased by 2.44% to $6666.0 in 2022.
  • Business Quant data shows Depreciation & Amortization (CF) for KBLB at $6666.0 in Q4 2022, $6716.0 in Q3 2022, and $7270.0 in Q2 2022.